Cyclo Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial Results
16.08.2022 - Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, ...
Source: wallstreet-online.de